Delivery Order SPE2DB24D2205-SPE2DB25FDSTB
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $13,531.42. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside and represents an award...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, which was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.46, is a delivery order contract with a firm fixed price, issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $5,838.86. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringe, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,304.70 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The $24,793.76 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. The contract does not have a set-aside designation and is intended to support the...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the supply of Dupixent 300 mg/2 ml syringe 2 ml, a specialty medical product. The $5,881.80 firm fixed-price contract is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military treatment facilities and other federal healthcare programs. The contract has an ultimate completion date of October 13, 2023, and...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency's (DLA) medical supply needs. The $9,803.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with an ultimate completion date of November 5, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, awarded to Amerisourcebergen Drug Corp. The $6,626.45 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency. The award has a completion date of December 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug Dupixent 300 mg/2 ml syringe. The $5,370.62 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 11, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,177.13, is for the supply of Dupixent 300 mg/2 ml syringes. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...